|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Martinez-Camblor P, Minguela A. Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases. Biomedicines. 2024 Oct 24;12(11):2439. doi: 10.3390/biomedicines12112439. PubMed PMID: 39595006; PubMed Central PMCID: PMC11592343.
AÑO: 2024; IF: 3.9
|
39595006
|
Novoa-Bolivar EM, Ros JA, Perez-Fernandez S, Campillo JA, Lopez-Hernandez R, Gonzalez-Lopez R, Otalora-Alcaraz A, Ortuno-Hernandez C, Gimeno L, Ruiz-Lorente I, Ceballos-Francisco D, Muro M, Solana E, Martinez-Camblor P, Minguela A. Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD. Cells. 2024 Dec 13;13(24):2066. doi: 10.3390/cells13242066. PubMed PMID: 39768157; PubMed Central PMCID: PMC11674578.
AÑO: 2024; IF: 5.1
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Escudero-Bregante JF, Ferri B, Campillo JA, Pons-Fuster E, Martinez Hernandez MD, Martinez-Sanchez MV, Ceballos D, Minguela A. Exploring the Immunoresponse in Bladder Cancer Immunotherapy. Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937. PubMed PMID: 39682686; PubMed Central PMCID: PMC11640729.
AÑO: 2024; IF: 5.1
|
|
Ruiz-Lorente I, Gimeno L, Lopez-Abad A, Lopez Cubillana P, Fernandez Aparicio T, Asensio Egea LJ, Moreno Aviles J, Donate Iniguez G, Guzman Martinez-Valls PL, Server G, Ferri B, Campillo JA, Martinez-Sanchez MV, Minguela A. Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with M. bovis BCG or Other Therapies. Biomedicines. 2025 Jan 10;13(1):156. doi: 10.3390/biomedicines13010156. PubMed PMID: 39857739; PubMed Central PMCID: PMC11760850.
AÑO: 2025; IF: 3.9
|
|
Pons-Fuster E, Martinez-Rodriguez R, Gimeno-Arias L, Alcaraz MJ, Moreno M, Gomez JM, Pelaez A, Garcia E, Tomas C, Munoz A, Martinez-Sanchez MV, Ruiz-Lorente I, Ceballos D, Minguela A, Bernal E. HLA-A*03 may confer protection against long COVID through an enhanced immune response. Infect Dis Now. 2025 Mar 17:105057. doi: 10.1016/j.idnow.2025.105057. Online ahead of print. PubMed PMID: 40107360.
AÑO: 2025; IF: 2.9
|